Glickman Richard M 4
4 · enGene Holdings Inc. · Filed May 29, 2024
Insider Transaction Report
Form 4
Glickman Richard M
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-05-28−120→ 0 totalExercise: $0.89→ Common Shares (120 underlying) - Exercise/Conversion
Common Shares
2024-05-28$0.89/sh+120$107→ 24,675 total
Footnotes (2)
- [F1]This option is fully vested and exercisable.
- [F2]This option was originally due to expire December 4, 2023, however prior to that date the expiration date was extended to 120 days following the filing of enGene Holdings Inc.'s Form S-8, which was filed February 27, 2024. Accordingly, the option expiry date is June 26, 2024.